160 related articles for article (PubMed ID: 37644910)
1. Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes.
Fayette L; Sailer MO; Perez-Pitarch A
CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1386-1397. PubMed ID: 37644910
[TBL] [Abstract][Full Text] [Related]
2. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
3. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
[TBL] [Abstract][Full Text] [Related]
4. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
6. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
7. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
8. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
9. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
10. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
Ji Z; Lin J; Lin J
J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
[TBL] [Abstract][Full Text] [Related]
11. Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program.
Chen MH; Ibrahim JG; Amy Xia H; Liu T; Hennessey V
Stat Med; 2014 Apr; 33(9):1600-18. PubMed ID: 24343859
[TBL] [Abstract][Full Text] [Related]
12. An adaptive power prior for sequential clinical trials - Application to bridging studies.
Ollier A; Morita S; Ursino M; Zohar S
Stat Methods Med Res; 2020 Aug; 29(8):2282-2294. PubMed ID: 31729275
[TBL] [Abstract][Full Text] [Related]
13. Bayesian dose-finding phase I trial design incorporating historical data from a preceding trial.
Takeda K; Morita S
Pharm Stat; 2018 Jul; 17(4):372-382. PubMed ID: 29372582
[TBL] [Abstract][Full Text] [Related]
14. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
[TBL] [Abstract][Full Text] [Related]
15. A model-based approach for historical borrowing, with an application to neovascular age-related macular degeneration.
Brizzi F; Steiert B; Pang H; Diack C; Lomax M; Peck R; Morgan Z; Soubret A
Stat Methods Med Res; 2023 Jun; 32(6):1064-1081. PubMed ID: 37082812
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
Chu Y; Yuan Y
Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
[TBL] [Abstract][Full Text] [Related]
17. A group-sequential randomized trial design utilizing supplemental trial data.
Kotalik A; Vock DM; Hobbs BP; Koopmeiners JS
Stat Med; 2022 Feb; 41(4):698-718. PubMed ID: 34755388
[TBL] [Abstract][Full Text] [Related]
18. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
19. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
20. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]